4basebio PLC (LON:4BB) Insider Purchases £28,920 in Stock

4basebio PLC (LON:4BB) insider Heikki Lanckriet acquired 2,400 shares of 4basebio stock in a transaction that occurred on Wednesday, April 2nd. The shares were purchased at an average price of GBX 1,205 ($15.53) per share, with a total value of £28,920 ($37,277.65).

4basebio Stock Up 1.7 %

Shares of 4BB stock opened at GBX 1,205 ($15.53) on Monday. The stock’s fifty day moving average price is GBX 1,142.07 and its 200 day moving average price is GBX 1,229.09. 4basebio PLC has a 1-year low of GBX 901 ($11.61) and a 1-year high of GBX 1,820 ($23.46). The company has a market cap of £154.36 million, a price-to-earnings ratio of -1,544.87 and a beta of 1.09. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reaffirmed an “outperform” rating and issued a GBX 1,600 ($20.62) price target on shares of 4basebio in a report on Thursday, March 13th.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.